跳至主要内容
临床试验/NCT04923503
NCT04923503已完成不适用

Department of Nutrition Science, Medical Faculty, Universitas Diponegoro, Semarang, Indonesia

Universitas Diponegoro2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
2
主要终点
change PYY

研究概览

简要总结

Diabetes Mellitus individuals are known to have dietary rules, namely regulating the amount, type and time of eating. Ramadan fasting seems to be beneficial for people who want to reduce their weight, but it is not easy for diabetic patients. Because of its distinctive features, Ramadhan induces changes in eating habits, calorie consumption, sleeping patterns, and daily physical activity, which may contribute to changes in hunger-satiety responses and glicemic control. Examining changes in gut hormones during Ramadan fasting may reveal whether this observance could change glucose metabolism in diabetics without triggering the undesirable effect of gluconeogenesis. The proportions of fat, protein, and carbohydrate in meals vary between outside and within Ramadan. Alterations in timing and composition meal during Ramadan lead to reduced food intake may affect gut hormones and metabolic responses. The aim of this study to determine whether the effect of Ramadan fasting differed in people with DM patients, pre-DM and healthy individuals, with respect to gut hormones, body composition, metabolic parameters, and glycemic control

详细描述

The experimental study was performed during and after Ramadan fasting in 2021 (April to May) in Semarang, Indonesia. The present study was performed using the quasy-experimental method by pre-post measurement of three experimental groups (diabetics, Obese and healthy subjects) selected using the purposive sampling methods

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

subject with random allocation Investigator do not know the group the analysator do not know the group

入排标准

年龄范围
35 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetics subjects: glucose fasting plasma > 200 mg/dL, with aged 35-60 years and body mass index above 25 kg/m;
  • Obese subjects: body mass index above 25 kg/m2 with aged 35-60 years and waist circumference for men >90 cm, for women > 80 cm
  • Lean subjects: body mass index below 23.5 kg/m2 with aged 35-60 years and waist circumference for men <90 cm, for women < 80 cm

排除标准

  • experienced weight loss more than 10% from the actual weight in the last three months
  • consumed medicine or supplement for weight loss diet, •. had the history of evidence of clinical depression, cognitive disorders, heart disease, cancer, liver or renal disease, chronic pulmonary disease, uncontrolled hypertension, physical disability, or other contraindications

结局指标

主要结局

change PYY

时间窗: 30 days

Change from Baseline PYY at 30 days taken in the lab from venous blood specimen

change insulin

时间窗: 30 days

Change from Baseline Insulin at 30 days taken in the lab from venous blood specimen

change acylated ghrelin

时间窗: 30 days

Change from Baseline acyl ghrelin at 30 days taken in the lab from venous blood specimen

change GLP-1

时间窗: 30 days

Change from Baseline GLP-1 at 30 days taken in the lab from venous blood specimen

次要结局

  • change body weight(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Etika Ratna Noer

Department of Nutrition, Medical Faculty

Universitas Diponegoro

研究点 (2)

Loading locations...

相似试验